News

Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to support Rigel's ongoing Phase 3 clinical trial to evaluate...

Dubai has launched a logistics alliance that aims to speed up distribution of Covid-19 vaccines around the world through the emirate. The Dubai Vaccines Logistics Alliance said it would combine Emirates SkyCargo’s air network with DP World’s worldwide network of...

Welcome relief from VOCs: Clariant unveils an innovative line of new sustainably-mined clay mineral-based DESVOCANT adsorbents to efficiently reduce the potential exposure of shipment handlers, merchants, and consumers to volatile organic compounds (VOCs) from enclosed manufactured products. VOCs can accumulate...

Gilead Sciences, Inc. and Gritstone Oncology, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the companies have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy...

Eli Lilly and Company has partnered with local health systems to launch dedicated infusion center locations serving central, northern, and now southern Indiana that are intended to provide Hoosiers with access to important COVID-19 treatments. Multiple neutralizing antibody therapies,...

Valneva SE , a specialty vaccine company focused on prevention against diseases with major unmet needs, reported that the UK Government has exercised its option to order 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate for supply...

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the...